Potential pitfalls of Viekira Pak™ therapy in patients with HCV genotype 1b cirrhosis

Crina Fofiu; Daniela Dobru; Alina Boeriu

doi:10.15403/jgld.2014.1121.261.pak

Potential pitfalls of Viekira Pak™ therapy in patients with HCV genotype 1b cirrhosis

Authors

Crina Fofiu Department of Gastroenterology, University of Medicine and Pharmacy Tirgu Mures, Tirgu Mures, Romania
Daniela Dobru Department of Gastroenterology, University of Medicine and Pharmacy Tirgu Mures, Tirgu Mures, Romania
Alina Boeriu Department of Gastroenterology, University of Medicine and Pharmacy Tirgu Mures, Tirgu Mures, Romania

DOI:

https://doi.org/10.15403/jgld.2014.1121.261.pak

Keywords:

Abstract

Published

2017-03-01

How to Cite

Fofiu C, Dobru D, Boeriu A. Potential pitfalls of Viekira Pak™ therapy in patients with HCV genotype 1b cirrhosis. JGLD [Internet]. 2017 Mar. 1 [cited 2026 Jul. 18];26(1):91-6. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/946